A new class of small molecule estrogen receptor-alpha antagonists that overcome anti-estrogen resistance

Yongxian Ma, Anju Preet, York Tomita, Eliseu De Oliveira, Li Zhang, Yumi Ueda, Robert Clarke, Milton Brown, Eliot M. Rosen

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Previous studies indicate that BRCA1 protein binds to estrogen receptor-alpha (ER) and inhibits its activity. Here, we found that BRCA1 over-expression not only inhibits ER activity in anti-estrogen-resistant LCC9 cells but also partially restores their sensitivity to Tamoxifen. To simulate the mechanism of BRCA1 inhibition of ER in the setting of Tamoxifen resistance, we created a three-dimensional model of a BRCA1- binding cavity within the ER/Tamoxifen complex; and we screened a pharmacophore database to identify small molecules that could fit into this cavity. Among the top 40 "hits", six exhibited potent ER inhibitory activity in anti-estrogen-sensitive MCF-7 cells and four of the six exhibited similar activity (IC50 ≤ 1.0 μM) in LCC9 cells. We validated the model by mutation analysis. Two representative compounds (4631-P/1 and 35466-L/1) inhibited ER-dependent cell proliferation in Tamoxifen-resistant cells (LCC9 and LCC2) and partially restored sensitivity to Tamoxifen. The compounds also disrupted the association of BRCA1 with ER. In electrophoretic mobility shift assays, the compounds caused dissociation of ER from a model estrogen response element. Finally, a modified form of compound 35446 (hydrochloride salt) inhibited growth of LCC9 tumor xenografts at non-toxic concentrations. These results identify a novel group of small molecules that can overcome Tamoxifen resistance.

Original languageEnglish (US)
Pages (from-to)40388-40404
Number of pages17
JournalOncotarget
Volume6
Issue number38
DOIs
StatePublished - 2015
Externally publishedYes

Keywords

  • Agonist
  • Antagonist
  • BRCA1
  • Estrogen receptor (ER-a)
  • Tamoxifen

Fingerprint Dive into the research topics of 'A new class of small molecule estrogen receptor-alpha antagonists that overcome anti-estrogen resistance'. Together they form a unique fingerprint.

Cite this